Discover 3,614 paid clinical trials in Orange County, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Orange County offers clinical trials for a variety of conditions, including high blood pressure, heart disease, and skin disorders such as eczema, alopecia, and psoriasis. The city’s medical institutions are actively recruiting both healthy volunteers, as well as those with specific health needs to participate in studies that could improve treatments and outcomes for these, and many other widespread health issues.
Filter
2
Filter results
Results: 3,614
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
for
Uterine Fibroids, Endometriosis
Location: Long Beach CA, Lomita CA, Inglewood CA, Los Angeles CA,
Sponsor: Sumitomo Pharma Switzerland GmbH
Sex: Female
Age: 18 - 50
Code: NCT05862272
Phase 3, Recruiting
Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant
for
E Coli Infections, Allogenic Transplant Patients
Location: Duarte CA, San Francisco CA, Seattle WA, Houston TX,
Sponsor: SNIPR Biome Aps.
Sex: All
Age: 18+
Code: NCT06938867
Phase 1, Phase 2, Recruiting
Optimizing Reperfusion to Improve Outcomes and Neurologic Function
for
Acute Ischemic Stroke
Location: Long Beach CA, Los Angeles CA, Sacramento CA,
Sponsor: Corxel Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT06990867
Phase 2, Phase 3, Recruiting
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
for
Cervical Cancer
Location: Duarte CA, Las Vegas NV, Phoenix AZ, Scottsdale AZ,
Sponsor: Pfizer
Sex: Female
Age: 18+
Code: NCT06952660
Phase 4, Recruiting
Screening for AL Amyloidosis in Smoldering Multiple Myeloma
for
Smoldering Multiple Myeloma
Location: Los Angeles CA, San Francisco CA, Salt Lake City UT,
Sponsor: Tufts Medical Center
Sex: All
Age: 40+
Code: NCT06365060
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
for
Lung Non-Small Cell Carcinoma
Location: Loma Linda CA, La Jolla CA, Modesto CA, Sunnyvale CA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06116682
Phase 2, Recruiting
Clinical Trial to Compare the Efficacy of Celiprolol to Placebo in Patients With Vascular Ehlers-Danlos Syndrome
for
Vascular Ehlers-Danlos Syndrome
Location: Culver City CA
Sponsor: Acer Therapeutics Inc.
Sex: All
Age: 15 - 64
Code: NCT05432466
Phase 3, Recruiting
Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis
for
AAA - Abdominal Aortic Aneurysm
Location: Irvine CA, Los Angeles CA, Palo Alto CA, Stanford CA,
Sponsor: W.L.Gore & Associates
Sex: All
Age: 18+
Code: NCT06218875
Recruiting
Health Care Transition Readiness Short-Form Video Intervention
for
Health Care Transition Readiness, Health Literacy,
Location: Los Angeles CA
Sponsor: Children's Hospital Los Angeles
Sex: All
Age: 12 - 17
Code: NCT06842576
Recruiting
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
for
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
Location: Anaheim CA, Irvine CA, Bellflower CA, Baldwin Park CA,
Location: Irvine CA, Phoenix AZ, Davis CA, Sacramento CA,
Sponsor: Direct Biologics, LLC
Sex: All
Age: 18 - 70+
Code: NCT05354141
Phase 3, Recruiting
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
for
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic,
Location: Irvine CA, Fullerton CA, Laguna Hills CA, Alhambra CA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07144280
Phase 3, Recruiting
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
for
Metastatic Castration Sensitive Prostate Cancer (mCSPC),
Location: Irvine CA, Laguna Hills CA, Alhambra CA, Torrance CA,
Sponsor: Pfizer
Sex: Male
Age: 18+
Code: NCT07028853
Phase 3, Recruiting
Intracerebroventricular Administration of CD19-CAR T Cells (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/Mem T-lymphocytes) for the Treatment of Central Nervous System Lymphoma
for
Central Nervous System Lymphoma
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT05625594
Phase 1, Recruiting
VenusP-Valve Pivotal Study (PROTEUS STUDY)
for
Pulmonary Regurgitation
Location: Irvine CA
Sponsor: Venus MedTech (HangZhou) Inc.
Sex: All
Age: 12+
Code: NCT06010563
Recruiting
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
for
Acute Leukemia
Location: Duarte CA, San Francisco CA, Albuquerque NM,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 2+
Code: NCT04811560
Phase 1, Phase 2, Recruiting
A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
for
Chronic Obstructive Pulmonary Disease With Chronic Bronchitis
Location: Westminster CA, Encino CA, Medford OR, Seattle WA,
Sponsor: UCB Biopharma SRL
Sex: All
Age: 40 - 70+
Code: NCT07725939
Phase 2, Recruiting
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
for
Heart Failure
Location: Huntington Beach CA, San Dimas CA, Inglewood CA,
Sponsor: AstraZeneca
Sex: All
Age: 40+
Code: NCT06677060
Phase 3, Recruiting
Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma